Asia Q3 Check In: Vaccine Rollouts and China’s Capital Markets with Paul Kim [PODCAST]
Wednesday, August 4, 2021

As Asia’s economies attempt to recover from the grip of COVID-19, they face added obstacles brought on by slow vaccine rollouts and new pandemic restrictions. We’re exploring the latest economic and regulatory developments in the Asia markets in Q3 including the impact of the new Delta variant of the virus, vaccinations, and China’s crackdown on ridesharing giant, Didi.

Joining me for this conversation is Seoul, Korea-based attorney, Paul Kim. Paul graduated in Economics from the University of Chicago, with highest honors, and obtained his Juris Doctorate degree from Harvard University.  Paul currently serves in private practice as a Corporate Partner in Sheppard Mullin’s Seoul office advising clients on cross-border mergers and acquisitions (M&A), private equity, venture capital and securities transactions, restructurings and multi-jurisdictional disputes.

What We Discussed in This Episode:

  • What precautions are various Asian countries taking to address the Delta variant of the coronavirus?

  • What is causing the slow vaccine rollouts in South Korea?

  • Why have Environmental, Social, Governances (ESG) become more popular in South Korea lately?

  • What type of public assistance is the government of South Korea offering individuals and businesses?

  • What lessons can be learned from how companies responded to supply chain deficiencies during the pandemic?

  • Which industries experienced economic growth during the pandemic?

  • Has China gone to war, proverbially, against public markets?

 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins